Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial | Norris Cotton Cancer Center
Skip to main content
x
Norris Cotton Cancer Center
In This Section
 
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
Principal Investigator (?)
Study Number
A151216
Summary
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient''s tumor cells may help doctors select the best treatment for patients that have certain genetic changes. 
Phase (?)
Phase III
Sponsor (?)
Available at the following location(s)

Lebanon,Manchester,Nashua,Southwestern Vermont

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.

0